Merck-Medco Analysis Finds 11% Of Rx Market Will Go Generic In 3-5 Years
Executive Summary
Merck-Medco projects that products representing 11% of current drug spending will have generic alternatives over the next three to five years.
You may also be interested in...
Caremark PBM Services Could Reduce Senior Rx Costs By 26.5%, Firm Says
Caremark's PBM services could reduce an uninsured senior citizen's average annual pharmaceutical spending by 26.5%, the company told a June 5 securities analysts meeting at its new Mount Prospect, Ill. mail order pharmacy.
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011